GLG Inc’s Pfizer PFE Stock Holding History

GLG Inc’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2013 Q3	–	Sell	-527,000	Closed	-$14M	–	751
2013 Q2	$14M	Buy	+527,000	New	+$14.6M	0.34%	49

Other funds holding PFE

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

GLG Inc's PFE Position: Q4 2013 in Review

GLG Inc increased its Pfizer (PFE) stake by 33% in Q4 2013, buying an estimated $7.73M and bringing the position to 1,065,078 shares worth $31M. The position accounts for 0.81% of the portfolio, ranked #20.

GLG Inc first reported a position in PFE in Q2 2013 and has held it in 3 quarters since. 1,735 funds tracked by Wall St. Rank hold PFE as of Q4 2013.

GLG Inc held 1,065,078 shares of Pfizer worth $31M as of Q4 2013.
GLG Inc bought 265,601 Pfizer shares in Q4 2013, an estimated $7.73M.
Pfizer made up 0.81% of GLG Inc's portfolio in Q4 2013, its #20 holding.
GLG Inc first reported a position in Pfizer in Q2 2013 and has held it in 3 quarters since.
1,735 funds tracked by Wall St. Rank held Pfizer as of Q4 2013.

Based on GLG Inc's 13F filing for Q4 2013, filed 14 Feb 2014.